Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6511 to 6525 of 7711 results

  1. Quizartinib for treating relapsed or refractory acute myeloid leukaemia [ID1325]

    Discontinued [GID-TA10363]

    Technology appraisal guidance
    Discontinued

  2. Lymphoma (non Hodgkin's, peripheral T-cell) - pralatrexate [ID368]

    Discontinued [GID-TAG424]

    Technology appraisal guidance
    Discontinued

  3. Leukaemia (acute myeloid, relapsed, refractory) - vosaroxin [ID746]

    Discontinued [GID-TA10070]

    Technology appraisal guidance
    Discontinued

  4. Moxetumomab pasudotox for treating hairy-cell leukaemia [ID1142]

    Discontinued [GID-TA10923]

    Technology appraisal guidance
    Discontinued

  5. Generalised anxiety disorder - quetiapine [ID347]

    Discontinued [GID-TAG421]

    Technology appraisal guidance
    Discontinued

  6. PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)

    This medtech innovation briefing has been updated and replaced by NICE medtech innovation briefing 313.

    Medtech innovation briefing
    Published
    25 March 2019

  7. UroShield for preventing catheter-associated urinary tract infections (MIB191)

    This advice has been updated and replaced by NICE medical technologies guidance 69.

    Medtech innovation briefing
    Published
    9 September 2019

  8. Alpha-Stim AID for anxiety (MIB193)

    This advice has been updated and replaced by NICE medical technologies guidance 56.

    Medtech innovation briefing
    Published
    16 September 2019

  9. DyeVert for reducing contrast media in coronary and peripheral angiography (MIB196)

    This advice has been updated and replaced by NICE medical technologies guidance 60.

    Medtech innovation briefing
    Published
    4 November 2019

  10. LiverMultiScan for liver disease (MIB181)

    This medtech innovation briefing has been updated and replaced by NICE diagnostics guidance on MRI-based technologies for assessing non-alcoholic fatty liver disease (DG50).

    Medtech innovation briefing
    Published
    26 April 2019

  11. SEM Scanner for pressure ulcer prevention (MIB182)

    This advice has been updated and replaced by NICE medical technologies guidance 51.

    Medtech innovation briefing
    Published
    8 May 2019

  12. FibroScan for assessing liver fibrosis and cirrhosis in primary care (MIB216)

    This advice has been updated and replaced by NICE diagnostics guidance 48.

    Medtech innovation briefing
    Published
    16 June 2020

  13. Prontosan for acute and chronic wounds (MIB220)

    This advice has been updated and replaced by NICE medical technologies guidance 67.

    Medtech innovation briefing
    Published
    28 July 2020

  14. Plus Sutures for preventing surgical site infection (MIB204)

    This advice has been updated and replaced by NICE medical technologies guidance 59.

    Medtech innovation briefing
    Published
    4 February 2020

  15. Leukomed Sorbact for preventing surgical site infection (MIB197)

    This advice has been updated and replaced by NICE medical technologies guidance 55.

    Medtech innovation briefing
    Published
    14 November 2019